Publisher: Frost & Sullivan
Category: Biomarkers

Biomarkers market research reports by Frost & Sullivan

(8 reports matching your criteria)
    • Precision Neurodegenerative Disease Market, Global, 2024–2028

      Precision Neurodegenerative Disease Market, Global, 2024–2028 Precision NDD Treatment is Experiencing Transformational Growth due to AI Capabilities, Disease-modifying Therapies, and Industry Convergence The rising global prevalence of neurodegenerative diseases (NDDs) is driving the shift from symp ... Read More

    • Growth Opportunities in the Tissue Diagnostics Industry, Global, 2024–2029

      Growth Opportunities in the Tissue Diagnostics Industry, Global, 2024–2029 Companion Diagnostics-specific Advanced Staining and Multiomics Capabilities are Driving Market Growth The global tissue diagnostics market will experience significant growth driven by the need for advanced staining in precis ... Read More

    • Trend Opportunity Profile Series: Health, Wellness, and Nutrition (Second Edition)

      Trend Opportunity Profile Series: Health, Wellness, and Nutrition (Second Edition) This edition of Trend Opportunity Profiles features trend advancements in health, wellness, and nutrition featuring sensors for food products or pharmaceutical drugs, sustainable nutrition, technology-induced healthca ... Read More

    • Global Precision Oncology Market - Trends and Growth Opportunities

      Global Precision Oncology Market - Trends and Growth Opportunities The procedure for accurately identifying a biomarker correlation based on a patient’s genetic makeup is complex and relies on the expertise and knowledge of an oncologist, decision-support scientist, or other healthcare professional ... Read More

    • Technology Advances and Growth Opportunities in Elderly Care

      Technology Advances and Growth Opportunities in Elderly Care Predictive Health Monitoring and Intelligent Assistance Drive the Industry’s Innovation Culture World Health Organization statistics state that by 2030, one out of six people will be 60 years of age or more. The aged population will likely ... Read More

    • Global Oncology Diagnostics in IVD Growth Opportunities

      Global Oncology Diagnostics in IVD Growth Opportunities By Leveraging Data-driven Solutions, Co-development Opportunities, and Assay Innovation, Clients Can Experience Enhanced Product Performance, Cost-effectiveness, and Improved Decision-making Capabilities The global oncology diagnostics in IVD m ... Read More

    • Cardiac Troponin Diagnostics-Forecasts and Opportunities to 2025

      Cardiac Troponin Diagnostics-Forecasts and Opportunities to 2025 Cardiac troponin (cTn) biomarkers are the gold standard in myocardial infarction (MI) diagnosis, leading healthcare professionals to use cTn diagnostics. In addition, a rising number of patients visit emergency departments (EDs) with c ... Read More

    • Growth Opportunities for Digital Biomarkers in Drug Development

      Growth Opportunities for Digital Biomarkers in Drug Development Pharmaceutical companies spend billions of dollars in drug development because of expensive and time-consuming clinical trials, with a meager success rate. Frequent clinical visits, manual data processing, and a lack of consistent data ... Read More

Research Assistance

Live help

Join Alert Me Now!

Sign Up

Find out more on our blog
Cookie Settings